Definitive Contract 75N93022C00046
Award Date
9/30/22
Potential Completion Date
9/29/24
Potential Value
$600K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Qoolabs Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This...
This is a small business set-aside contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a woman-owned small disadvantaged business in California. The $300,000 firm-fixed-price contract is for the development of affinity reagents for the immune system of guinea pigs. Qoolabs Inc. has previously received over $4 million in prime federal contracts from HHS agencies like NIAID and NCI for research and...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc., a self-certified small disadvantaged business, for the development of affinity reagents for the immune system of guinea pigs. The $300,000 firm-fixed-price contract was awarded under the SBIR program and has a completion date of June 30, 2021. Qoolabs Inc. is a corporate entity that has received over $4 million in prime...
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a small disadvantaged business located in Carlsbad, California. The contract is for research and development under the Small Business Innovation Research (SBIR) program, with a period of performance through September 2025. Qoolabs is developing medical technologies related to infectious diseases, immunology,...
This is a $1,500,000.00 SBIR Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qoolabs Inc., a small disadvantaged and woman-owned business located in Carlsbad, California. The contract is for research and development of medical technologies related to infectious diseases, immunology, and COVID-19 detection, including the development of affinity reagents,...
This is a $1,500,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Qoolabs Inc., a woman-owned small disadvantaged business located in Carlsbad, California. The contract is for the production of affinity reagents for the immune system of guinea pigs, including interleukins IL1B, IL2, IL4, IL6, IL8, IL10, IL12, and IL13. There was no set-aside used for this award. Qoolabs Inc. has extensive...
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This $300,000 firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for the development of point-of-care hepatitis C virus core antigen detection and was awarded under the Small Business Innovation Research program's solicitation PHS-2021-1. This total small business set-aside opportunity sought proposals for innovative...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,336 firm fixed price purchase order to Innovive, LLC of San Diego, California. The contract is for the delivery of maximum containment hamster caging and rack system accessories to support NIH research activities. No set aside designation or subcontractors were identified. The award will provide needed equipment for the NIH's research into infectious...